Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Joseph Gligorov

1-50 of 105 results

View this query on the Wikidata Query Service
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

scientific article
1st International consensus guidelines for advanced breast cancer (ABC 1).

scientific article published on 16 March 2012
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

scientific article published on 01 September 2007
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

scientific article
Preclinical pharmacology of the taxanes: implications of the differences.

scientific article published on January 2004
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

scientific article
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

scientific article published on 19 August 2013
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

scientific article published on 28 February 2012
Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial.

scientific article published on 28 September 2014
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, rando

scientific article published on 28 September 2014
Adjuvant treatments for triple-negative breast cancers

scientific article published on August 1, 2012
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

scientific article published on 28 July 2014
Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

scientific article published on 21 May 2007
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

scientific article published on 14 May 2014
Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

scientific article
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study

scientific article published on 15 March 2008
A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

scientific article
Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast can

scientific article published on July 2005
Pregnancy-associated breast cancers: do they differ from other breast cancers in young women?

scientific article published on 13 June 2012
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Resu

scientific article published on 19 January 2005
Prevalence and Treatment Management of Oropharyngeal Candidiasis in Cancer Patients: Results of the French Candidoscope Study

article
Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged <35 years: a GET(N)A Working Group analysis.

scientific article published in November 2009
Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data

scientific article published on 23 December 2014
Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectives.

scientific article published on 16 August 2007
Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients.

scientific article
Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design

scientific article published on 08 October 2011
Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis.

scientific article published on 12 December 2008
Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence

scientific article published on 07 July 2010
Cardiovascular safety profiles of aromatase inhibitors : a comparative review.

scientific article published on January 2006
Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider

scientific article published on November 2010
Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients

scientific article published on 11 May 2013
Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

scientific article published on 13 August 2013
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study

scientific article published on 03 June 2014
Cost-effectiveness of a chemotherapy predictive test

scientific article
Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer

scientific article
Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy.

scientific article published on 6 August 2010
Does Concurrent Radiochemotherapy Affect Cosmetic Results in the Adjuvant Setting After Breast-Conserving Surgery? Results of the ARCOSEIN Multicenter, Phase III Study: Patients’ and Doctors’ Views

scientific article published on 01 May 2007
Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant setting

scientific article
Docetaxel in the treatment of breast cancer: current experience and future prospects.

scientific article
The use of breast cancer subtype classification to predict local and distant recurrence. A review

article
Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors

scientific article published on 9 December 2011
The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer

scientific article published on 2 February 2018
Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer

scientific article
Malignant cardiac tumors

scientific article
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol

scientific article published in April 2006
Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

scientific article published in November 2011
Pulmonary Artery Obstruction and Giant Cell Arteritis

scientific article published on 01 May 1995
Discordance With Local Guidelines for Adjuvant Chemotherapy in Breast Cancer: Reasons and Effect on Survival

scientific article published on 01 March 2011
Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France.

scientific article published on August 2012
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance).

scientific article

Paulina is supported by:

About Paulina

Help